The Patent Finder

Fatty Liver Disease Treatment Using Glucocorticoid and Mineralocorticoid Receptor Antagonists

Corcept Therapeutics Incorporated

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 62/092,041, filed Dec 15, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,238,659Fatty Liver Disease Treatment Using Glucocorticoid and Mineralocorticoid Receptor Antagonists
In force
 · High confidence
UsedRemaining
Corcept Therapeutics, Inc.In forceHigh confidence
US 10,881,660Fatty Liver Disease Treatment Using Glucocorticoid and Mineralocorticoid Receptor Antagonists
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 11,590,135Fatty Liver Disease Treatment Using Glucocorticoid and Mineralocorticoid Receptor Antagonists
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 12,226,417Fatty Liver Disease Treatment Using Glucocorticoid and Mineralocorticoid Receptor Antagonists
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
Application 19/014,779Fatty Liver Disease Treatment Using Glucocorticoid and Mineralocorticoid Receptor Antagonists
Pending
Not granted
Corcept Therapeutics, Inc.PendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Corcept Therapeutics Incorporated.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited